Skip to content

13F-HR filed by JW Asset Management, LLC

JW Asset Management, LLC filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-12, with 40 holding rows worth $153,148,000.

Accession
0001420506-16-000969
Filed
2016-05-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2016

A holdings report, 40 entries on the cover page, a total value of $153,148,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $153,148,000 with VALUE read as thousands by filing date, 13F file number 028-16404. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EAGLE PHARMACEUTICALS INC269796108COM760,379$30,795,000thousands by filing date
META PLATFORMS INC CL A30303M102COM131,755$15,033,000thousands by filing date
Starbucks Corporation855244109COM230,690$13,772,000thousands by filing date
ALLERGAN PLCG0177J108SHS44,189$11,844,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS673,075$11,153,000thousands by filing date
BLACKSTONE GROUP LP09253U108COM UNIT LTD295,009$8,275,000thousands by filing date
ARALEZ PHARMACEUTICALS INC03852X100COM1,836,375$6,519,000thousands by filing date
CONCORDIA HEALTHCARE CORP206519100COM245,400$6,282,000thousands by filing date
Amazon.com, Inc023135106COM9,339$5,544,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON474,439$5,238,000thousands by filing date
Alphabet Inc. Reg. Shares C02079K107COM6,064$4,517,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW36,174$3,874,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK221,538$3,542,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM25,424$3,540,000thousands by filing date
QLT INC746927102COMMON STOCK1,592,993$3,170,000thousands by filing date
WINGSTOP INC COM974155103Stock116,057$2,632,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM72,649$2,530,000thousands by filing date
JUNIPER PHARMACEUTICALS INC COM48203L107Stock328,132$2,169,000thousands by filing date
Netflix, Inc64110L106COM17,484$1,787,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM53,373$1,709,000thousands by filing date
DEPOMED INC249908104COM117,924$1,643,000thousands by filing date
CAMBREX CORP132011107COM35,148$1,547,000thousands by filing date
SAGENT PHARMACEUTICALS INC786692103COM101,630$1,237,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock189,919$982,000thousands by filing date
CHIPOTLEMEXICANGRILLI169656105STOK2,000$942,000thousands by filing date
DIGIRAD CORP253827109COM110,257$547,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM30,140$436,000thousands by filing date
AKORN INC009728106COM16,506$388,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM17,974$351,000thousands by filing date
TELIGENT INC NEW87960W104COM63,820$313,000thousands by filing date
XENOPORT INC98411C100COM50,000$226,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM20,000$169,000thousands by filing date
ANTARES PHARMA INC036642106COM142,198$124,000thousands by filing date
PJT PARTNERS INC69343T107COM CL A5,000$120,000thousands by filing date
MEDICAL TRANSCRIPTION BLG CO58464J105COM63,771$65,000thousands by filing date
CUMBERLAND PHARMACEUTICALS I230770109COM10,939$49,000thousands by filing date
SECOND SIGHT MED PRODS INC81362J100COM8,500$41,000thousands by filing date
CTI BIOPHARMA CORP COM NEW12648L106Stock50,254$27,000thousands by filing date
BIOTA PHARMACEUTIALS INC090694100COM8,611$13,000thousands by filing date
NANOSPHERE INC COM NEW63009F204Stock3,451$3,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-16-000969this filing2016-05-12acceptance time not in the bulk data set